Literature DB >> 24858965

Changes of procalcitonin level in multiple trauma patients.

Marek Wojtaszek1, Grzegorz Staśkiewicz, Kamil Torres, Krzysztof Jakubowski, Oliver Rácz, Elżbieta Cipora.   

Abstract

BACKGROUND: Some aspects of the pathophysiology of complications in multiple-trauma patients still remain unclear. Mediators of inflammation have been postulated as playing a key role in being responsible for life threatening complications of multiple trauma patients. The objective of this study was to evaluate the prognostic value of procalcitonin (PCT) level in multiple trauma patients.
METHODS: A prospective study took place including patients with multiple trauma hospitalised in several hospital units. PCT level was measured in blood from 45 patients, aged 18-70 years using enzyme-linked immunoassay. The patients were divided into three groups: group I - individuals with multiple trauma with central nervous system injury; group II - those with multiple trauma without CNS injury; and group III - patients with isolated central nervous system injury.
RESULTS: Initial PCT levels were below 0.5 ng mL(-1) regardless of the cause of trauma. In the 24th hour of observation, a statistically significant increase of PCT concentration vs. initial levels was recorded in all groups of patients. Then PCT levels decreased significantly at the 3rd measurement point in all groups, and they remained unchanged until the last measurement. The highest levels of PCT were observed in multiple trauma patients without CNS injury (group II). In this group of patients, a significantly longer duration of surgery in the post-trauma period affected PCT levels. PCT concentrations in patients who died were significantly greater than in survivors.
CONCLUSIONS: A long lasting elevated concentration of procalcitonin in the post-traumatic period, or its repeated increase, is a good marker of developing complications observed earlier than clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24858965     DOI: 10.5603/AIT.2014.0015

Source DB:  PubMed          Journal:  Anaesthesiol Intensive Ther        ISSN: 1642-5758


  6 in total

Review 1.  The role of procalcitonin in reducing antibiotics across the surgical pathway.

Authors:  Massimo Sartelli; Luca Ansaloni; Michele Bartoletti; Fausto Catena; Maurizio Cardi; Francesco Cortese; Francesco Di Marzo; Federico Pea; Mario Plebani; Gian Maria Rossolini; Gabriele Sganga; Bruno Viaggi; Pierluigi Viale
Journal:  World J Emerg Surg       Date:  2021-03-24       Impact factor: 5.469

Review 2.  Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities.

Authors:  Hamed Fouladseresht; Atefe Ghamar Talepoor; Nahid Eskandari; Marzieh Norouzian; Behrooz Ghezelbash; Mohammad Reza Beyranvand; Seyed Aria Nejadghaderi; Kristin Carson-Chahhoud; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

3.  Can APACHE II, SOFA, ISS, and RTS Severity Scores be used to Predict Septic Complications in Multiple Trauma Patients?

Authors:  Sebastian Trancă; Cristina Petrișor; Natalia Hagău; Constantin Ciuce
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-08-10

4.  A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole Blood.

Authors:  Mark Cartwright; Martin Rottman; Nathan I Shapiro; Benjamin Seiler; Patrick Lombardo; Nazita Gamini; Julie Tomolonis; Alexander L Watters; Anna Waterhouse; Dan Leslie; Dana Bolgen; Amanda Graveline; Joo H Kang; Tohid Didar; Nikolaos Dimitrakakis; David Cartwright; Michael Super; Donald E Ingber
Journal:  EBioMedicine       Date:  2016-06-13       Impact factor: 8.143

5.  The prognostic value of serum procalcitonin measurements in critically injured patients: a systematic review.

Authors:  Aziza N AlRawahi; Fatma A AlHinai; Christopher J Doig; Chad G Ball; Elijah Dixon; Zhengwen Xiao; Andrew W Kirkpatrick
Journal:  Crit Care       Date:  2019-12-03       Impact factor: 9.097

Review 6.  A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine.

Authors:  Anna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette; Marta Vecchi; Ilaria Coledan; Elda Righi; Evelina Tacconelli
Journal:  Ann Transl Med       Date:  2020-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.